Vietnam’s Deputy Prime Minister Tran Hong Ha has recently cited Decision No. 1165/QD-TTg as a significant milestone in Vietnam’s pharmaceutical sector. The Decision includes the National Strategy for developing the country’s pharmaceutical industry until 2030, with a vision extending to 2045.
The primary goals are to ensure that all residents have access to affordable medication and to propel Vietnam’s pharmaceutical sector, aligning it with the standards of advanced nations in the region.
These strategies are expected to bring medications to most Vietnamese people at affordable prices while enhancing medical availability. The Decision will also support research capacities and make the most of current technological advancements to generate unique brand-name medications and contemporary dosage forms.
Vietnam wants to establish itself as a major center for the production, processing, and transfer of technology for brand-name medications, especially those coming from ASEAN. In addition, the nation is working to get its domestic pharmaceutical sector satisfied WHO level 4 standards.
By 2030, the nation aims to have a complete drug supply for disease prevention and treatment; protect drug security to meet demands of national defense, security, and disease prevention and control; and deal with the fallout from crises, natural disasters, public health emergencies, and other urgent medical needs.
In addition, the digital transformation of the pharmaceutical business is another crucial component of the strategy. One of the key projects is to digitize all data and information related to medications. This data will be updated in the Pharmaceutical Industry Data Bank.
(Source: Vietnam News)
